Introduction
Cerebrovascular reactivity (CVR) can be defined as the capacity of blood vasculature to increase cerebral perfusion through vasodilatation to meet the energy requirements of the brain tissue [1] . The CVR gives an indication as to how close the brain is to the exhaustion of the reserve capacity, and therefore may have prognostic potential for portending stroke risk and/or guiding treatment decisions [2] [3] [4] . Decreased regional CVR has been suggested to be an independent predictor of 5-year stroke risk [3] . Also, it has been shown that patients, with steno-occlu-sive cerebrovascular disease and a decreased CVR have a 35% risk of developing an ischemic stroke, while patients with a normal CVR only have an 11% risk [3] . In patients with moyamoya disease (MMD) and decreased CVR, a surgical anastomosis may improve the long-term prognosis by improving cerebral hemodynamics [2] . Furthermore, the CVR can be used to identify patients eligible for carotid endarterectomy [4] . Positron emission tomography (PET), single-photon emission CT (SPECT) and transcranial Doppler ultrasonography (TCD) have always been the golden standard for the assessment of the CVR. More recently, alternative, noninvasive methods like blood oxygen level-dependent (BOLD) MRI and arterial spin labelling (ASL) MRI have been developed to evaluate the CVR. Both BOLD and ASL MRI have demonstrated great potential to evaluate the CVR [5, 6] . However, due to the large amount of studies that have been performed in different patient groups and with different imaging sequences and post-processing algorithms, it is currently unclear if there is a consistent difference in BOLD and ASL CVR between patients with cerebrovascular disease and healthy control subjects. Additionally, literature has not settled upon CVR thresholds for tissue at risk and a proper universally defined way to express CVR is still lacking; for example, CVR can be presented in %BOLD, %BOLD/mm Hg, % cerebral blood flow (CBF)/mm Hg and ΔCBF. Therefore, BOLD and ASL MRI can currently not be used as prognosticators for stroke risk. The main aim of the current systematic review was therefore to describe and to interpret the CVR results of ASL and BOLD MRI studies performed in patients with steno-occlusive cerebrovascular disease or stroke. The second goal of this study was to try to provide reference CVR values for both normal and abnormal perfused brain tissue.
Background

Vasodilatory Challenges
Different techniques are used to cause a vasodilatory challenge and therefore an increase in CBF and cerebral blood volume (CBV), which is consequently used to determine the CVR [7] . A first approach is to modulate a subject's PaCO 2 , thereby inducing an increase in tissue perfusion through vasodilatation of the cerebral vasculature. For this, either hypercarbic gas administration (in combination with atmospheric air) or carbogen (hypercarbic hyperoxia) are used [8] . More simply, subjects could just be told to hold their breath increasing the PaCO 2 and therefore the CBF. A second approach is the administration of acetazolamide (ACZ), a carbonic anhydrase inhibitor. Inhibition of carbonic anhydrase causes carbonic acidosis, which induces a considerable increase in CBF [9] . The third commonly used approach is to induce a functional task, which increases the blood flow toward a specific region.
PET Imaging, SPECT Imaging and Transcranial Doppler Ultrasonography
PET and SPECT have always been the brain imaging standard for the assessment of the CVR. In both methods, the CVR is measured by means of a vasodilatory challenge. Unfortunately, both PET and SPECT are invasive, as they make use of ionizing radiation, and in the case of 15-O PET, an onsite cyclotron is required. Therefore, they are less suited for clinical use in nonspecialized centers [10] .
TCD is noninvasive technique that has the goal to assess hypercapnia-mediated changes in CBF at the level of the brain feeding vessels [11] . To enable this, changes in measured peak blood velocity from baseline to hypercapnia are transformed to changes in CBF, and from these the CBF reactivity is estimated [12] . A disadvantage of TCD is that it does not assess CVR at the brain tissue level and that it assumes that the insonated arterial diameter remains stable throughout hypercapnia [13] . In addition, some other factors, for example, blood pressure, influence the reliability of CBF measurements [14] .
BOLD and ASL MRI
BOLD and arterial spin labeling (ASL) MRI are noninvasive and provide information on the status of brain parenchyma [15] . CVR values measured by BOLD or ASL MRI were shown to correlate with SPECT values [16, 17] .
BOLD MRI measures changes in the T2 * of blood and tissue water secondary to decreases in the amount of venous capillary and venule deoxyhemoglobin (dHb) [18] . Specifically, in case of BOLD CVR measurements, a vasodilatory challenge increases CBF and CBV in the brain parenchyma while inducing a much smaller change in metabolism. As such, information regarding CVR can be inferred from the dHb reductions in and around veins.
Contrary to BOLD measurements that are related to a combination of CBF, CBV, and oxygen consumptions, ASL MRI measures the CBF solely and quantitatively. This is achieved by magnetically labeling the arterial blood water protons at the level of the brain-feeding ves-sels. These labeled blood protons then travel upstream through the blood vessels and exchange with tissue water protons. At this point in time, a 'labeled image' is made, which is subtracted from a nonlabeled 'control image' to obtain a perfusion-weighted image. CBF can be quantified in absolute units (e.g. ml blood/100 g tissue/min) upon application of appropriate kinetic models. Similar to BOLD MRI, a vasodilatory challenge is added to obtain the CVR.
Methods
No ethical committee approval was deemed necessary to conduct this literature review.
Search Strategy and Selection Criteria
To be eligible for inclusion in this systematic review, published articles had to concern ASL-and/or BOLD reactivity studies performed in patients with cerebrovascular steno-occlusive disease or stroke. In October 2015, 2 authors (D.P.J.S. and J.B.V.) performed an electronic based search using the PubMed/MEDLINE and Embase database. The search was performed using the following search terms: (cerebrovascular disorders OR stroke OR occlusion OR stenosis OR ischemia) AND (ASL OR BOLD OR blood flow) AND (magnetic resonance imaging OR MRI OR MR). Letters, comments, abstracts for conferences, case reports, studies that included ≤ 3 participants, studies including children, animal studies and articles written in languages other than English, Dutch, German or French were excluded. Also, articles had to present quantitative study results to be eligible for inclusion. No further restrictions were made. Articles were screened and duplicates were removed. Figure 1 shows a flowchart of the search using the PRISMA statement [19] .
Quality Assessment
The methodological quality of all included studies was assessed using an adjusted version of a recent review on delayed cerebral ischemia [20] . Studies were assessed on design, aim, population selection, study size and outcome presentation ( table 1 ) . Studies were predefined as high quality with a score of 6, as intermediate quality with a score of 4 or 5 and as a low quality with a score of 3 or less.
Data Extraction
The following data were extracted from the studies: first author, year of publication, study design, the country in which the study was performed, imaging modality (ASL and/or BOLD), MRI field strength, the type of cerebrovascular disease (occlusion, stenosis, stroke or MMD), the affected vessel, number of patients (male/ 291 female), patients characteristics (age and gender), number of controls and their characteristics, type and dose of challenge used (breath holding, carbon dioxide inhalation, ACZ (Diamox) or functional task), the evaluated region, the results of the hemisphere ipsilateral to the affected artery, the results of the contralateral hemisphere if available, and the results of the control group if available.
Data Analysis
The data of all included studies were presented systematically in tables and figures. To overcome the lack of a proper universally defined CVR definition, all CVR data were converted to the same units if possible; for example, all CO 2 study results were converted to percent signal change per change of 10 mm Hg in endtidal CO 2 Collaboration, 2014). Mean differences (MD) with 95% CI were calculated using the inverse variance method with a random effects model. Statistical heterogeneity was examined using the Tau 2 test, the chi-square test, the degrees of freedom, the I 2 statistic and the overall effect Z test.
Results
Search
The flowchart of the study selection process is illustrated in figure 1 . The search in PubMed/MEDLINE identified 5,989 articles, and the search in Embase identified 10,890 articles. After screening, removing duplicate articles and assessing full-text articles, we found a total of 31 articles eligible for inclusion [5-7, 16, 17, 21-46] . Articles about moyamoya patients were included only if lateralizing disease was present in them. Lateralizing disease was defined as symptoms being more related to one hemisphere than to the other one.
Quality Assessment
A total of 4 studies were assessed as having a high quality. All other studies had an intermediate quality score ( table 1 ) . Most studies had an intermediate score due to a low score on the number of included patients. In only 6 (19.4%) studies, 25 or more patients were included. All studies had clearly described inclusion and exclusion criteria and had a clear research question.
Baseline Characteristics
The characteristics of all included studies are described in table 2 . The publication date of the articles ranged from 1999 until 2015. All studies were published in English. Of the total 31 included studies, 27 (87.1%) were prospective and 4 (12.9%) were retrospective studies. The studies included a total of 600 patients (60% men). The study sample size ranged from 3 to 60 patients with a mean of 19 patients. Twenty-three (74.2%) studies used BOLD MRI to evaluate the CVR, 4 (12.9%) studies used ASL MRI, and 4 (12.9%) studies used both BOLD and ASL MRI. A 3 tesla scanner was used in 22 (71.0%) studies, a 1.5 tesla MRI system in 8 (25.8%) studies, and in one study, the MRI field strength was not reported. Two studies were performed in patients with occlusion of one or more of the brain feeding arteries, 9 studies were performed in patients with stenosis of the brain feeding arteries, 8 studies were performed in stroke patients, 2 studies were performed in patients with MMD, and 10 studies included patients of several of the above-mentioned categories (mixed disease). In case of stenosis of the brain feeding arteries, the percentage of stenosis was provided when given in the article ( table 2 ) .
Data Extraction
Different challenges were used to provoke a vascular response and as such to obtain a reactivity measurement; in 15 studies, a breathing challenge was performed; in 10 studies, a functional task was executed; in 3 studies, ACZ was administered; and in 3 studies, an external stimulation was applied ( table 2 ). Studies were performed at different time windows, and this is especially of importance in studies investigating stroke patients. In these particular studies, 3 studies investigated CVR in the acute phase, 1 study investigated the CVR in the subacute phase, 5 studies investigated the CVR in the chronic phase and 2 studies performed CVR measurements at different time intervals. A few studies presented more than just one study result. From these studies, we only demonstrated the measurements that were deemed most relevant for our study purpose. In the study of Pineiro et al. [34] , the results of the right-hand movements were used because more data of these were presented than for the left-hand movements. In the study of Heyn et al. [29] , the results of patients with pial collaterals were used. In the study of Donahue et al. [26] , the results of the hemispheres (n = 7) with the highest disease categorization, as quantified from the modified Suzuki score, were used [47] .
BOLD and ASL Study Results
Example ASL and BOLD images are shown in figures 2 and 3 . Figure 2 shows the images of a patient with an occlusion of both internal carotid arteries who presented with asymmetric disease on the ASL CBF, ASL CVR and BOLD CVR images. The reactivity results of 6 studies, which evaluated the results using an asymmetry index, the number of activated voxels or calculated z-statistics, are shown in table 4 . Figure 4 shows the BOLD CVR results in a bar plot of the 21 studies, which presented a percentage signal change. The values shown in this bar plot are presented in table 3 . Thirteen studies found a lower CVR in the ipsilateral compared to the contralateral hemisphere [5, 25, 26, 28, 29, 31, 33, 35, 38-40, 43, 46] . Three of these 13 295 studies found significant differences [5, 28, 33] . Two studies showed similar results in the ipsilateral and contralateral hemispheres [27, 42] . Three studies showed a higher CVR in the ipsilateral compared to the contralateral hemispheres; none of these 3 studies found a significant result [21, 32, 34] . The residual 3 studies did not show the results of either the ipsilateral or the contralateral hemisphere. In 10 of the BOLD CVR studies, a healthy control group was included [5, 16, 22, 25, 34, 37, 38, 40, 42, 46] . Nine of these 10 studies showed a lower CVR in the ipsilateral hemispheres of the patients compared to the CVR measured in the healthy controls, and 5 of these 9 studies found significant differences [5, 22, 34, 40, 42] . Noteworthy to the reader is that the low %BOLD CVR in Donahue et al. [26] and Geranmayeh et al. [42] is caused by the normalization of the %BOLD CVR changes by the end-tidal CO 2 . Figure 5 shows the results of the 7 studies in which ASL MRI was used and the percentage signal change is presented in this figure. Six studies found a lower CVR in the hemisphere compared to the left. Right hemisphere: ASL CBF: 41 ml/100 g/min, ASL CVR: 67 ml/100 g/min, BOLD CVR: 3.0% signal change. Left hemisphere: ASL CBF: 24 ml/100 g/min, ASL CVR: 81 ml/100 g/min, BOLD CVR: 2.2% signal change. 298 ipsilateral compared to the contralateral hemispheres, 2 of these studies found a significant difference [6, 17, 23, 24, 32, 40] . Five studies compared the ASL CVR results of patients to the ASL CVR results of a healthy control group and found a lower ASL CVR in the ipsilateral hemispheres of the patients compared to the ASL CVR measured within the healthy control group [6, [22] [23] [24] 40] . Three of these studies found significant differences. No study found an equal or higher ASL CVR ipsilaterally compared to contralaterally, or, equal or higher ASL CVR in the patients compared to the controls.
Subgroup Analyses
In the BOLD studies, subgroup analyses demonstrated a significantly lower BOLD CVR in the ipsilateral hemispheres of studies who included patients with stenosis (n = 5) or included a mixed group of patients (n = 4; fig. 6 ). Subgroup analyses in the stroke studies (n = 3) and in the MMD studies (n = 2) did not demonstrate significant differences.
Subgroup analyses were not performed for the included ASL studies because only 7 studies could be included; this in turn led to too low numbers in the subgroups. The I 2 value for heterogeneity was 97%, which shows a high heterogeneity. The results from heterogeneity tests for the different subgroups are shown in figure 6 .
Safety Analyses
A solid safety analysis was performed in one of the included papers, and they reported claustrophobia in 1.6%. More importantly, within this study, no stroke-like symptoms outside the range of what should be expected were found [7] . One group reported anxiety evoked by hypercapnic breathing in 13% of their patients, and Bouvier et al. [39] reported discomfort due to the face mask in 9% of the patients [40] .
Discussion
For the first time, this review groups the results of BOLD and ASL CVR measurements in cerebrovascular disease and thereby gives a comprehensive overview of the BOLD and ASL CVR data present in the literature. Overall, as expected, the results presented in this systematic review bring support for a reduced BOLD and ASL CVR in the ipsilateral hemisphere of patients with stenoocclusive cerebrovascular disease. When combining the BOLD CVR results of all studies concerning patients 
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BOLD and ASL CVR Results in Cerebrovascular Disease
A majority of the BOLD and ASL CVR studies found a significant lower CVR in the ipsilateral compared to the contralateral hemisphere. Still, 3 studies using BOLD MRI showed a higher, though not significant, BOLD CVR in the ipsilateral compared to the contralateral hemispheres [21, 32, 34] . One of them was the study of Mandell et al. [32] who found a BOLD CVR of 4.13 ± 8.08% in the ipsilateral and 3.08 ± 0.80% in the contralateral hemisphere. Though, when scrutinizing their data we noticed an outlier within their results (case number 25; BOLD CVR ipsilateral: 2.82% and contralateral: 0.33%). This outlier skewed their BOLD results, and in fact, when the results of this case were not included in the analyses, the results were the opposite: the ipsilateral hemispheres than had a lower CVR compared to the contralateral hemispheres (ipsilateral: 1.27 ± 1.28%; contralateral: 3.06 ± 0.84%). This outlier may be caused by an error in their BOLD measurement as they did find lower ASL CVR in the ipsilateral compared to the contralateral hemisphere of this subject (ipsilateral: 0.30% and contralateral: 5.27%). Another study that found higher BOLD CVR in the ipsilateral hemisphere was the study of Pineiro et al. [34] (ipsilateral: 1.22 ± 0.40%; contralateral: 1.13 ± 0.37%). In their discussion, the higher BOLD CVR response on the ipsilateral side was attributed to an increased ipsilateral blood flow and blood volume as a consequence of increased synaptic activity. However, it should be noticed that the difference in results between ipsilateral and contralateral hemispheres were only minor and insignificant. Also, they did find a lower BOLD CVR in the ipsilateral hemisphere of patients compared to the controls. The third and last study, which found a higher CVR ipsilaterally, was the study by Altamura et al. [21] who attributed this to the decreased fMRI signal detection in hemodynamic impaired patients resulting in more noise within the data. A reason as to why studies could find a higher CVR ipsilaterally could be cerebral metabolic rate of oxygen (CMRO 2 ) upregulation in the ipsilateral hemisphere [48] . CMRO 2 upregulation can be caused by a hypercarbic hyperoxia stimulus (carbogen) in which the tissue that is hypoxic at baseline metabolizes the additional oxygen provided and therefore artificially decreases the relative amount of dHb being present, thus creating a falsely increased CVR. In essence, this would mean that an increased CVR is a surrogate marker of impaired CMRO 2 [49, 50] . However, this could be confirmed only when BOLD CVR measurements are combined with CBF/CBV measurements. Another reason for a higher CVR in the ipsilateral hemisphere could be the baseline vasodilation status of poorly perfused tissue. This hypothesis finds support in the enhanced hypocapnia reactivity observed within stroke patients [6] . Therefore, additional hypocapnia challenges may help identify the level of vascular compliance in patients with reduced cerebral perfusion [51] . Something to take into account when interpreting the studies who found a higher CVR ipsilaterally is that 2 out of the 3 studies applied a functional task or an auditory stimulus [21, 34] . This makes the interpretation of the increased BOLD responses in light of cerebrovascular disease much more complex due to task-induced changes in neurovascular coupling, CMRO 2 and other confounding factors [52, 53] .
The Effect of Time Window after Stroke Onset
As described previously, the studies performed in stroke patients were performed at different time intervals after stroke onset and thereby introduce clinical diversity in this systematic review. The evolution of the CVR after stroke has not been investigated thoroughly so far, though we did include one paper that measured the CVR both in the acute and subacute stroke phases. In this paper, a higher BOLD CVR in the ipsilateral hemispheres in the acute phase (ipsilateral: 0.60 ± 0.16%; contralateral: 0.54 ± 0.30%) compared to the subacute phase (ipsilateral: 0.40 ± 0.16%; contralateral: 0.44 ± 0.09%) was found [21] . This was thought to originate from an increase in the time to peak latency, that is, the time that it takes for the BOLD signal to reach its maximum signal change after the initiation of the stimulus, when patients advance from the acute to the subacute phase [21] . If this would in fact be the case, then these differences would be overcome by discarding the images acquired during the latency period.
Inter-Trial Variability
A second important finding of this review is that there is wide variability within the obtained BOLD and ASL CVR measurements. The BOLD CVR measurements ipsilaterally ranged from -0.02 to 4.13%, the contralateral results ranged from 0.19 to 3.08%, and the controls ranged from 0.3 to 2.29%. The ipsilateral results in ASL MRI ranged from 5.8 to 52.2%, the contralateral results ranged from 6.8 to 53.15%, and the controls ranged from 7.5 to 65.4%. This finding might correlate with the fact that there is no universally defined manner to measure the CVR in combination with a nonuniform way of presenting the results. Apart from this wide variability, one can also notice that there is a considerable overlap between the different groups presented in the different papers. For example, the patients in the study of Goode et al. [27] have BOLD values in a similar range in their ipsilateral hemisphere as the CVR values found in the contralateral hemispheres of the study of Mazzetto-Betti et al. [33] or Mandell et al. [32] . Despite this overlap, there seems to be a trend toward higher CVR values from the ipsilateral to the contralateral hemisphere and to the control hemispheres. The variability in BOLD and ASL values are multifactorial. The variability in measure-ments can be explained both by clinical and methodological diversity.
Methodological diversity is introduced by differences in sequences and post-processing algorithms in between vendors and research groups, differences in the field strength of the magnet, and differences in vasodilatory stimuli as well as timing of imaging after administration of the vasodilatory stimulus. One of these differences in between sequences is the postlabel delay, which is used in ASL MRI and ranged from 1,000 to 2,500 ms in the included studies [22, 32] . When a shorter postlabel delay is used, the label may still be present in the vasculature at the time of imaging, causing an overestimation of the CBF and based on the results found in the presented studies, as well from the CVR [32, 54] . This is specifically important within the investigated population as subjects with cerebrovascular disease are known to have longer arterial transit times compared to healthy controls and are thus more prone to an overestimation when too short of a postlabel delay is used [55] . Ideally the postlabel delay would have been adjusted on an individual basis by determining the subject's transit time using for instance a look-locker readout [56] . This would have made the comparison between patients and healthy controls more accurate, although it would demand more imaging time, which is not always possible. A second major contributor to methodological diversity is the impact of MRI field strength on signal-to-noise ratio (SNR). Both BOLD and ASL MRI benefit from higher SNR and therefore study results could significantly differ depending on field strength. From the studies included in this systematic review, 8 studies were performed on 1.5T and 22 studies on 3T and no big differences were found in their study results. Another difference that can cause wide variability in the measurements is the vasodilatory challenge itself. Different functional tasks, different doses of ACZ, different timing of imaging after ACZ administration, differences in hypercapnia level and different breath-hold techniques were used causing different CVR responses [57] . Specifically from breath-holding it is known to cause varying outcome among individuals due to subject-physiology and the fact that not all patients can hold their breath as long [58] . Also, even when a similar CO 2 or carbogen level is administered to the patient, interindividual differences will arise based on differences in respiratory rate and ventilation volume. Ideally, the hypercapnia challenge would be based on EtCO 2 measurements to guarantee a similar challenge in all subjects. Another factor that has to be taken into account is that a hypercapnic challenge not only affects flow amount but also decreases arterial transit time by increasing flow velocity [59, 60] . In case of decreased or stagnant flow at baseline, which is common in patients with cerebrovascular disease, changes in arterial transit time can confound CVR measurements. This could be problematic as CVR is most likely to be overestimated and thus will induce systematic errors. Another remark is that blood T 1 is affected by carbogen and this could impact CBF quantification in ASL-based CVR studies [61] . The BOLD signal is a complex outcome of flow and metabolism, which may both change during a hypercapnic stimulus, and thereby make BOLD CVR less interpretable in the sense of pathophysiology [60, 62, 63] . Additionally, functional tasks are known to alter neurovascular coupling with an unequal increase in both CBF as in CMRO 2 which results in the outcome that a functional task cannot be considered a true CVR measurement [64] [65] [66] . Nevertheless, we did decide to include these studies as they are commonly used due to their ease of implementation as compared to other vasodilatory stimuli. However, we do want to point out that out of the 7 studies with significant differences in BOLD CVR between the ipsilateral and contralateral hemisphere, 3 studies applied a functional task [22, 33, 34] . In addition to these studies not necessarily reflecting 'pure' CVR, their study results could also have been affected by poor task performance of the subjects.
Clinical diversity is introduced by differences in timing of imaging after onset of the disease, differences in stenosis grade as shown in table 2 , heterogeneous physiologic baseline conditions such as baseline brain metabolism and quantities such as hematocrit, which is known to influence the T 1 of blood [67, 68] . Thus far, all of these technique-related differences refrain us from obtaining BOLD and ASL CVR reference values for normal and abnormal perfused brain tissue.
Clinical Applicability and Safety Aspects
The advantage of BOLD and ASL CVR MRI measurements, as compared to the earlier performed PET and SPECT CVR measurements, is their noninvasiveness characteristic. To be clinically applicable, the techniques should also be clinically feasible, patient friendly and safe. So far, this latter issue has not been investigated thoroughly, as most of the studies covered within this review did not provide information of adverse events or side effects. Based on the studies that provide this information, we can deduce that in general, the CVR measurements seem to be safe and reasonably tolerable making it appropriate to be used in clinical practice. This was confirmed in a large cohort study which applied a prospectively targeted hypercapnia stimulus in 434 patients and found this to be safe [69] .
Strengths and Limitations
The strength of this systematic review is that it systematically presents the results of BOLD and ASL CVR studies performed so far in patients with cerebrovascular disease. This allows interested clinicians or researchers working within this field to get a comprehensive overview of the available data. A previously published review did look into the BOLD and ASL CVR MRI studies performed in carotid steno-occlusive disease, but they did not provide a systematic overview of the resulting BOLD and ASL CVR results [70] . Also, in our review, data are presented for different subgroups of cerebrovascular disease: stroke, stenosis, occlusion and MMD respectively. Likewise, clinical diversity is present in this review as studies included different groups of patients (occlusion, stenosis, stroke and moyamoya). In figure 6 , a subgroup analysis has been performed to see if a subgroup showed contrary results compared to other groups, which was not the case. However, this could have been expected in advance due to large heterogeneity based on the clinical and methodological diversity mentioned earlier.
Unfortunately, most of the studies included in this paper scored intermediate on the quality assessment, mainly due to their sample size. A potential limitation of this review is that we limited our search to quantitative studies, thereby restricting the amount of included papers. The reason as to why we choose to only include quantitative studies is that these study results have the potential to be compared. Also, a previous study demonstrated that a quantitative decrease in CVR is a better predictor of recurrent stroke than a qualitative decrease [3] . This was confirmed by Yokota et al. [71] who showed that a qualitative change was not a significant independent predictor in stroke patients with occlusive large-artery disease. However, the inclusion of only quantitative studies could have led to publication bias in our results. A thorough investigation of publication bias could not be performed in this review, as this would require similar functional tasks in all included studies. It is known that the effect of ACZ, CO 2 and functional tasks on the obtained CVR differs.
Another limitation of this review is that the patient characteristics of the presented studies are not fully comparable. As described in the section 'inter-trial variability', disadvantages of the current literature on BOLD and ASL CVR data are the unstandardized vasodilatory methods, different BOLD and ASL MRI sequences and different post-processing techniques. This is reflected in the high heterogeneity, which was found in the studies included in the subgroup analyses.
Future Directions
Although BOLD and ASL CVR measurements hold great promise, the absence of reference values is the largest obstacle that needs to be overcome before applying these noninvasive, and thus high-potential, techniques in daily clinical care. In this context, it is worth mentioning the effort performed by Sobczyk et al. [ 72 ] who generated a BOLD CVR reference atlas and even demonstrated this one to be useful to detect abnormal BOLD CVR values [73] . However, in order to make full use of such a reference atlas across centers, there is a need to identify a uniform stimulus and standardize the quantification procedure. Also, in order to adopt CVR measurements in clinical practice, future studies should consistently report adverse events and safety. Once standardized protocols, for both sequences and vasodilatory challenges, are achieved, new studies should be performed to obtain reference CVR values both in the healthy and the diseased. Prospective studies investigating the relation between CVR and stroke risk should be started. These studies could then be used to establish reference values that would enable us to identify the hemodynamically impaired patients. Because, even though recent trials were halted, as they did not find benefit of surgery over best medical care, it could be that surgery increases survival risk in those patients who are hemodynamically impaired the most [73] [74] [75] [76] . Treatment decisions could thus be based on both CVR results and the clinical symptoms, and selected patients could be offered additional treatment [77] .
Conclusion
This review gives, for the first time, an overview of all the quantitative study results of CVR measurements performed in patients with cerebrovascular disease or stroke. As expected, the results support a reduced CVR in the ipsilateral hemisphere of patients with steno-occlusive cerebrovascular disease or stroke. However, the main accomplishment of this review is that it maps the variability within the obtained results, which is caused by nonuniformity of the performed studies. Therefore, we suggest that future studies will be performed in a uniform way so that reference values for poorly perfused and healthy brain tissue are established and could be used to guide treatment decisions in patients with cerebrovascular disease.
